Jacqueline Azelvandre, DO
Family Medicine · Longwood, FLNPI 1639160831
Payments from drug & device makers
Across 332 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Lilly USA, LLC$922
- Boehringer Ingelheim$662
- Novo Nordisk$371
- Pfizer$363
- AbbVie$354
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,322100%
- Education$310%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 78 | $1,932 |
| Lilly USA, LLC | 55 | $922 |
| Boehringer Ingelheim | 34 | $662 |
| Novo Nordisk | 19 | $371 |
| Pfizer | 26 | $363 |
| AbbVie(2 entities) | 21 | $354 |
| Amarin Pharma, Inc. | 19 | $254 |
| Vanda Pharmaceuticals Inc. | 8 | $240 |
| Merck | 15 | $230 |
| Idorsia Pharmaceuticals US Inc | 10 | $194 |
| Exact Sciences | 7 | $129 |
| GSK | 7 | $124 |
| Abbott | 6 | $110 |
| Bayer | 4 | $92 |
| Amgen | 3 | $69 |
| Eisai Inc. | 4 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Esperion Therapeutics, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Amneal Pharmaceuticals LLC | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Shire North American Group Inc | 1 | $21 |
| Genentech USA, Inc. | 1 | $17 |
| Millicent US Inc | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Almatica Pharma LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$628
- BREZTRI AEROSPHERE$236
- BREZTRI$132
- JARDIANCE$114
How this compares
$6,352 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 40 | $59,478 |
| MounjaroTirzepatide | 23 | $22,951 |
| EliquisApixaban | 17 | $21,377 |
| JardianceEmpagliflozin | 13 | $12,042 |
| Lagevrio (Eua)Molnupiravir | 14 | $5,040 |
| SynthroidLevothyroxine Sodium | 38 | $4,295 |
| Levothyroxine Sodium | 298 | $2,429 |
| Atorvastatin Calcium | 242 | $2,169 |
| Pantoprazole Sodium | 76 | $1,596 |
| Losartan Potassium | 220 | $1,426 |
| Metoprolol Succinate | 100 | $1,212 |
| Bupropion XlBupropion Hcl | 37 | $1,006 |
| Rosuvastatin Calcium | 89 | $992 |
| Amlodipine Besylate | 176 | $970 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $928 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $371 | $59,47840 claims |
| Lilly USA, LLCMounjaro | $922 | $22,95123 claims |
| PfizerEliquis | $363 | $21,37717 claims |
| Boehringer IngelheimJardiance | $662 | $12,04213 claims |
| MerckLagevrio (Eua) | $230 | $5,04014 claims |
| AbbVieSynthroid | $354 | $4,29538 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $26 | $2,429298 claims |
| Almatica Pharma LLCSertraline Hcl | $13 | $56651 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Longwood
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.